The Medicines Company
Controlling Perioperative Hypertension with Cleviprex Reduces Risk of Heart Attack and of Death Following Cardiac Surgery, According to New Analyses
Published in Lab Law Weekly, July 18th, 2008
The Medicines Company (NASDAQ: MDCO) announced that data from two post-hoc analyses of the ECLIPSE trial showed that use of Cleviprex(TM) (clevidipine butyrate) injectable emulsion to control blood pressure during cardiac surgery may be associated with a reduced risk of heart attack compared to two of three currently used IV antihypertensive agents. In a separate sub-analysis, Cleviprex was associated with a lower 30-day mortality compared to two nitrovasodilators.
The two sub-analyses from ECLIPSE were presented during a poster session held at the annual meeting of the Society of Cardiovascular Anesthesiologists (SCA). In the first analysis, investigators examined the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2008-07-18)
More Articles from Lab Law Weekly
- a Journey for 9/11
Retired NFL Great George Martin's Historic ''a Journey for 9/11'' Charitable Walk Will End in San Diego on Saturday, June 21 - A.M. Best Co.
BestWeek: After the Fall, Fence Mending at AIG - Adventrx Pharmaceuticals, Inc.
ADVENTRX Settles Dispute With Former Licensee - Aetna
StarLine Group Provides Organ Transplant Options Through New Agreement with Aetna's Cofinity - Alchemia Ltd.
Alchemia Patents Granted for Generic Fondaparinux - American Federation of Government Employees
Council of Prison Locals Calls for Emergency Funding From Justice Department - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
